— Know what they know.
Not Investment Advice

NPHC OTC

Nutra Pharma Corp.
1W: +0.0% 1M: +0.0% 3M: -66.7% YTD: -66.7% 1Y: +0.0% 3Y: -66.7% 5Y: -93.3%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $715973 mcap · 7.09B float · 0.0094% daily turnover · Short 36% of daily vol

Balance Sheet Trends

Total Assets
$755K -3.2% ▼
5Y CAGR: +14.1%
Total Liabilities
$13M -39.4% ▼
5Y CAGR: +17.8%
Shareholders Equity
-$12M +40.7% ▲
Cash & Investments
$0 -100.0% ▼
Total Debt
$9M +4.4% ▲
5Y CAGR: +19.8%
Net Debt
$9M +5.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$0-$217K-$143K$91K$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$0-$217K-$143K$91K$0
Net Receivables$17K$32K$40K$325K$22K
Inventory$35K$8K$5K$31K$24K
Other Current Assets$63K$225K$143K$0$225K
Total Current Assets$115K$58K$55K$534K$334K
Property, Plant & Equip.$10K$214K$159K$139K$332K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$16K$68K$88K$108K$89K
Total Non-Current Assets$26K$282K$246K$246K$421K
Total Assets$141K$340K$302K$780K$755K
— Liabilities —
Accounts Payable$475K$583K$599K$672K$727K
Short-Term Debt$4M$7M$5M$8M$8M
Deferred Revenue$2M$123K$201K$2M$0
Other Current Liabilities$122K$1M$4M$9M$811K
Total Current Liabilities$6M$11M$11M$21M$13M
Long-Term Debt$51K$908K$253K$517K$254K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$51K$1M$313K$517K$432K
Total Liabilities$6M$12M$12M$22M$13M
— Equity —
Common Stock$4M$6M$7M$7M$7M
Retained Earnings-$61M-$68M-$69M-$82M-$74M
Accumulated OCI$0$0$0$0$470K
Total Stockholders Equity-$6M-$12M-$11M-$21M-$12M
Total Liabilities & Equity$141K$340K$302K$780K$755K
— Key Metrics —
Total Debt$4M$8M$5M$8M$9M
Net Debt$4M$9M$5M$8M$9M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms